China · Biotechnology startup
China · Sironax
Sironax is a clinical-stage biotechnology company that develops novel products and treatments for age-related degenerative diseases.
Funding reportedLast round: Series B
Follow Sironax and see its new rounds in your feed. Start following
What company datasets say Sironax raised
Funding, as reported
Reported in all301Min the source's currency
Rounds3
Last roundSeries B
Last round dateAug 2022
Investors listed14
Founders and team
From Sironax's own website: 3 on the team.
- Corporate LeadersPresident and Chief Executive Officer
- David HernandezVice President, Clinical Operations
- Dr. Anand RajarethinamVice President, Data Sciences & IT
Biotechnology in China
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Sironax in front of investors. Or tell us what we have wrong.